- Home
- BXSL vs LNTH Comparison
BXSL vs LNTH Comparison
Compare BXSL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXSL
- LNTH
- Stock Information
- Founded
- BXSL 2018
- LNTH 1956
- Country
- BXSL United States
- LNTH United States
- Employees
- BXSL N/A
- LNTH N/A
- Industry
- BXSL Trusts Except Educational Religious and Charitable
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BXSL Finance
- LNTH Health Care
- Exchange
- BXSL Nasdaq
- LNTH Nasdaq
- Market Cap
- BXSL 7.5B
- LNTH 7.5B
- IPO Year
- BXSL N/A
- LNTH 2015
- Fundamental
- Price
- BXSL $31.14
- LNTH $77.47
- Analyst Decision
- BXSL Buy
- LNTH Strong Buy
- Analyst Count
- BXSL 6
- LNTH 5
- Target Price
- BXSL $31.38
- LNTH $133.80
- AVG Volume (30 Days)
- BXSL 1.0M
- LNTH 1.3M
- Earning Date
- BXSL 05-07-2025
- LNTH 05-07-2025
- Dividend Yield
- BXSL 9.89%
- LNTH N/A
- EPS Growth
- BXSL N/A
- LNTH N/A
- EPS
- BXSL 3.14
- LNTH 3.53
- Revenue
- BXSL $1,380,706,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- BXSL $13.05
- LNTH $5.81
- Revenue Next Year
- BXSL $7.20
- LNTH $12.26
- P/E Ratio
- BXSL $9.92
- LNTH $22.69
- Revenue Growth
- BXSL 16.76
- LNTH 12.53
- 52 Week Low
- BXSL $25.89
- LNTH $74.34
- 52 Week High
- BXSL $34.64
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- BXSL 60.82
- LNTH 26.85
- Support Level
- BXSL $29.07
- LNTH $78.61
- Resistance Level
- BXSL $30.04
- LNTH $83.60
- Average True Range (ATR)
- BXSL 0.51
- LNTH 3.75
- MACD
- BXSL 0.32
- LNTH -3.08
- Stochastic Oscillator
- BXSL 88.62
- LNTH 0.35
About BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.